Jubilant Pharmova's stock surged 12% on Friday, hitting a new high of ₹1,169.55 on the BSE. While the Sensex dropped 0.02%, the pharma company's stock showed significant momentum. In the past month, Jubilant Pharmova gained 38%, far outpacing the Sensex's 5% rise. Over six months, the stock soared by 114%, doubling from ₹546.60. Investors are drawn to its strong performance, backed by the company's robust growth prospects and positive market sentiment around the pharmaceutical sector, especially due to Rekha Jhunjhunwala's interest in the stock.